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Torsades de Pointes is a life-threatening arrhythmia associated with a number of 
causes, but is very rare among endocrinologic disorders. We report a case of male 
pseudohermaphroditism with hyperaldosteronism due to a 17α-hydroxylase defi-
ciency presented with sudden cardiac arrest.
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INTRODUCTION
Deficiency of 17α-hydroxylase is a rare autosomal recessive disorder which causes 
congenital adrenal hyperplasia.1 Defects in the synthesis of cortisol and compensato-
ry hypersecretion of adrenocorticotropic hormone (ACTH) stimulate the synthesis 
of a large quantity of 11-deoxycorticosterone (DOC) and corticosterone in adrenal 
glands. High concentrations of DOC, which is a potent mineralocorticoid, lead to 
hyperaldosteronism which results in hypertension, hypokalemia, and a suppressed 
renin-angiotensin system. In gonads, the absence of 17α-hydroxylase activity pro-
hibits the synthesis of androgens, causing pseudohermaphroditism in males and sex-
ual infantilism with primary hypogonadism in females.2 Aldosterone excess with 
subsequent hypokalemia leads to the prolongation of the QT interval,3,4 which may 
increase the risk of fatal arrhythmias such as polymorphic ventricular tachycardia 
(Torsades de Pointes), although these are very rare in subjects with hyperaldosteron-
ism. We report a case of male pseudohermaphroditism due to 17α-hydroxylase defi-
ciency presented with malignant arrhythmias, Torsades de Pointes.
CASE REPORT
The 31-year-old woman was presented to our emergency room with an episode of 
resuscitated sudden cardiac arrest. She suddenly collapsed at her office, where, 
upon arrival, the emergency medical technician documented no pulse, and cardio-
pulmonary resuscitation was started and continued until the patient reached our 
hospital. An initial electrocardiogram revealed a normal sinus rhythm with left ven-
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droepiandrosterone (0.8 ng/mL; reference, 1.8-12.5 ng/mL) 
and cortisol (4.93 ng/mL; reference, 70-250 ng/mL) were 
decreased, while plasma 11-hydroxycorticosterone (76.0 
ug/dL; reference, 8.0-30.0 ug/dL) and ACTH (420.5 pg/
mL; reference, 7.2-63.3 pg/mL) were markedly elevated. 
Follicle stimulating hormone (30.9 mIU/mL; reference, 
1.3-8.1 mIU/mL) and luteinizing hormone (19.6 mIU/mL; 
reference, 1.0-5.3 mIU/mL) were elevated; however, testos-
terone was undetectable.
Abdominal computed tomography showed bilateral hy-
perplasia of adrenal glands (Fig. 2). Chromosome analysis 
for karyotype showed a 46, XY normal male karyotype, 
and genomic polymerase chain reaction direct sequencing 
tricular hypertrophy and a markedly prolonged QT interval 
(QTc=635 ms) (Fig. 1A). In the intensive care unit, recurrent 
episodes of Torsades de Pointes developed, which were ter-
minated spontaneously (Fig. 1B) or by DC shock (Fig. 1C). 
Echocardiographic assessment revealed severe left ventricu-
lar hypertrophy with normal systolic function. The patient 
did have a past history of primary amenorrhea and had been 
treated for hypertension with hydrochlorothiazide and val-
sartan. Initial laboratory evaluation revealed severe hypoka-
lemia of 1.6 mmol/L (reference, 3.5-5.5 mmol/L). Plasma 
renin activity was decreased (0.13 ng/mL/hr; reference, 
0.15-2.23 ng/mL/hr), but aldosterone level was elevated 
(270.1 pg/dL; reference, 29.9-158.8 pg/dL). Plasma dehy-
Fig. 1. ECG and arterial blood pressure recording. (A) The 12-lead ECG at the emergency room shows a markedly prolonged QT interval 
(QTc=635 ms). (B) Spontaneous termination of Torsades de Pointes. Note the short-long-short initiation of polymorphic ventricular tachy-
cardia. (C) Torsades de Pointes with hemodynamic compromise, which was terminated by biphasic shock of 100 J. The ABP waveform 
became flat after the occurrence of Torsades de Pointes. ABP, arterial blood pressure; ECG, electrocardiogram.
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peraldosteronism. In this case report, hyperaldosteronism 
due to 17α-hydroxylase deficiency and diuretics might 
cause severe hypokalemia, leading to Torsades de Pointes. 
Low extracellular potassium produces hyperpolarization 
and prolongation of the action potential duration, resulting 
in Torsades de Pointes triggered activity.5 Moreover, a hy-
pertrophic heart is known to be attributable to baseline in-
creased transmural dispersion of repolarization and is more 
susceptible to develop Torsades de Pointes.6,7 Accordingly, 
this patient was at a very high risk of life-threatening ar-
rhythmia and, surprisingly, her first presenting symptom 
was sudden cardiac arrest. Although the majority of cases 
of sudden cardiac arrest are caused by underlying cardiac 
disease vulnerable to fatal ventricular arrhythmia, including 
myocardial infarction with a low ejection fraction or con-
gestive heart failure and electrical disorders,8 several endo-
crinologic disorders seem to present with sudden cardiac 
death. In the literature, fatal sudden cardiac arrest as a first 
manifested symptom was reported in patients with endocri-
nologic disorders such as anterior pituitary insufficiency 
and aldosterone producing adrenal adenoma.9,10 Although 
all of the endocrinologic disorders associated with sudden 
arrest show a similar mechanism of QT prolongation caused 
by hypokalemia, their underlying diseases are likely to be 
heterogeneous. Male pseudohermaphroditism is a rare endo-
crinologic disorder and sudden cardiac arrest is a very un-
usual presenting symptom of this disease. To our knowl-
edge, this is the first report of male pseudohermaphroditism 
presented with sudden cardiac arrest. This case demonstrates 
for CYP17A1 confirmed the diagnosis of 17α-hydroxylase 
deficiency. After treatment with parenteral replacement of 
potassium and dexamethasone concurrent with antihyper-
tensive medications, including captopril (300 mg/day), cil-
nidipine (20 mg/day), and spironolactone (100 mg/day), no 
more Torsades de Pointes was noted and QTc was normal-
ized (Fig. 3). 
DISCUSSION
We report a case of male pseudohermaphroditism with 
life-threatening arrhythmia as the first manifested symp-
tom. A deficiency of 17α-hydroxylase is well known to 
cause male pseudohermaphroditism, combined with hy-
Fig. 2. Abdominal computed tomography showed bilateral hyperplasia of 
adrenal glands (arrows).
Fig. 3. Clinical course of the patient. Serial variations in plasma ACTH, systolic blood pressure (SBP), corrected QT interval (QTc), serum 
cortisol, and potassium (K+) are shown. ACTH, adrenocorticotropic hormone; HD, hospital day.
 ACTH (pg/mL) 420.5 435 84.1 4.75 2.98
 SBP (mm Hg) 230 180 120 110 120
 QTc (ms) 635 495 467 430 435
 Cortisol (ng/mL) 5.7 14.6 4.93 0.8 0.4
 K+ (mmol/L) 1.6 3.3 4.7 6.2 4.6
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that it is important to consider endocrinologic disorders 
among various causes in the diagnostic work-up, when a pa-
tient presents sudden cardiac arrest with a long QT interval. 
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